A pneumonia outbreak associated with a new coronavirus of probable bat origin

Peng Zhou,Xing-Lou Yang,Xian-Guang Wang,Ben Hu,Lei Zhang,Wei Zhang,Hao-Rui Si,Yan Zhu,Bei Li,Chao-Lin Huang,Hui-Dong Chen,Jing Chen,Yun Luo,Hua Guo,Ren-Di Jiang,Mei-Qin Liu,Ying Chen,Xu-Rui Shen,Xi Wang,Xiao-Shuang Zheng,Kai Zhao,Quan-Jiao Chen,Fei Deng,Lin-Lin Liu,Bing Yan,Fa-Xian Zhan,Yan-Yi Wang,Geng-Fu Xiao,Zheng-Li Shi
DOI: https://doi.org/10.1038/s41586-020-2012-7
IF: 64.8
2020-02-03
Nature
Abstract:Abstract Since the outbreak of severe acute respiratory syndrome (SARS) 18 years ago, a large number of SARS-related coronaviruses (SARSr-CoVs) have been discovered in their natural reservoir host, bats 1–4 . Previous studies have shown that some bat SARSr-CoVs have the potential to infect humans 5–7 . Here we report the identification and characterization of a new coronavirus (2019-nCoV), which caused an epidemic of acute respiratory syndrome in humans in Wuhan, China. The epidemic, which started on 12 December 2019, had caused 2,794 laboratory-confirmed infections including 80 deaths by 26 January 2020. Full-length genome sequences were obtained from five patients at an early stage of the outbreak. The sequences are almost identical and share 79.6% sequence identity to SARS-CoV. Furthermore, we show that 2019-nCoV is 96% identical at the whole-genome level to a bat coronavirus. Pairwise protein sequence analysis of seven conserved non-structural proteins domains show that this virus belongs to the species of . In addition, 2019-nCoV virus isolated from the bronchoalveolar lavage fluid of a critically ill patient could be neutralized by sera from several patients. Notably, we confirmed that 2019-nCoV uses the same cell entry receptor—angiotensin converting enzyme II (ACE2)—as SARS-CoV.
multidisciplinary sciences
What problem does this paper attempt to address?